STUDY SEARCH RESULTS

26 studies found for your search request:  alzheimer's

[11C]MK-6884 Positron Emission Tomography (PET) Tracer Validation Trial (MK-6884-001)
Condition: Alzheimer's Disease
Minimum Age: 18 years, Maximum Age: 85 years
Gender: Both
Study ID: NCT02621606
Status: Completed

[18F]MK-3328 as a possible novel positron emission tomography (PET) tracer for the detection of brai...
Condition: Alzheimer’s Disease
Minimum Age: 18 years, Maximum Age: 85 years
Gender: Both
Study ID: NCT01385033
Status: Terminated (Halted Prematurely)

[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001)
Condition: Alzheimer's Disease, Amnestic Mild Cognitive Impairment
Minimum Age: 18 years, Maximum Age: 85 years
Gender: Both
Study ID: NCT02562989
Status: Completed

A Study of MK-2214 in Adults with Mild Cognitive Impairment or Mild-to-Moderate Alzheimer’s Disease ...
Condition: Alzheimer disease
Minimum Age: 50 years, Maximum Age: 80 years
Gender: All
Study ID: NCT05466422
Status: Recruiting
Has Enrolling Locations in US or Canada

A Study of the Safety, Tolerability, and Pharmacodynamics of MK-8931 in Participants with Alzheimer'...
Condition: Alzheimer's Disease
Minimum Age: 50 years, Maximum Age: 85 years
Gender: Both
Study ID: NCT01496170
Status: Completed




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site